Comparison of early clinical results following total hip arthroplasty using an anterolateral direct anterior or approach: a randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034361

Enrollment

Unknown

Registered

2020-07-03

Start date

2020-07-15

Completion date

Unknown

Last updated

2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage hip joint disease

Interventions

Group A:anterolateral approach

Group B:direct anterior approach

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 80 years; 2. Primary total hip replacement due to end stage hip joint disease.

Exclusion criteria

Exclusion criteria: 1. Active infection; 2. Previous ipsilateral hip surgery; 3. Neuropathy of the limbs on the surgical side; 4. One-stage bilateral total hip arthroplasty; 5. Can not do MRI examination; 6. Mentally ill and inability to complete a variety of questionnaire scoring.

Design outcomes

Primary

Measure	Time frame
Harris hip score;western Ontario and McMaster universities osteoarthritis index;Oxford Hip Score;Short Form 12 Health survey Questionnaire;VAS pain score;Duration of operation;Perioperative total blood loss;creatinine kinase (CK);myoglobin;LFCN injury;Postoperative complications;Radiographic outcomes;UCLA Activity-Level Rating;	—

Countries

China

Contacts

Public ContactJie Xu

Fujian Provincial Hospital

jiexud@126.com+86 13950481734

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026